Britain probing AstraZeneca-Alexion deal over competition concerns


Article content

Britain’s competition regulator said on Tuesday it has started a probe into AstraZeneca’s $39 billion takeover of U.S. drugmaker Alexion for possibly reducing competition in the UK market or elsewhere.

The Competition and Markets Authority said it was inviting comments from any interested party on the deal to help with its assessment. It has set a deadline of June 3 for the insight from any stakeholders.

Anglo-Swedish drugmaker AstraZeneca agreed to buy Alexion in December in its largest ever deal, diversifying away from its fast-growing cancer business in a bet on rare-disease and immunology drugs. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Devika Syamnath)

See also  UPSC Civil Services 2021: Complete strategy and preparation tips for prelims



Source link

See also  Japan resumes rescue work after deadly landslides, 20 missing-Kyodo

Latest

Kremlin may restrict more food exports to shield it from high prices

Russia has warned that it is prepared to continue with its export curbs on key food products after recent price rises prompted the Kremlin to...

Financial watchdog bans crypto exchange Binance from UK

The UK’s financial watchdog has ordered Binance to stop all regulated activities in Britain and imposed stringent requirements in a stinging rebuke of...